Company Filing History:
Years Active: 2016
Title: The Innovations of Stefan Hartmann
Introduction
Stefan Hartmann is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of vaccine development, particularly in the production of live vector vaccines. His work focuses on creating vaccines that are highly attenuated and contain minimal or no animal-derived components.
Latest Patents
Stefan Hartmann holds a patent titled "Depletion of host cell components from live vector vaccines." This invention addresses the challenges associated with producing live vaccines that are both effective and safe. The patent outlines methods for the production and purification of live enveloped viruses suitable for vaccination, emphasizing the use of specifically designed cell lines as producer substrates.
Career Highlights
Stefan Hartmann is associated with Probiogen AG, a company dedicated to advancing biopharmaceuticals and vaccine technologies. His expertise in vaccine development has positioned him as a key figure in the industry, contributing to innovative solutions that enhance vaccine safety and efficacy.
Collaborations
Stefan has collaborated with notable colleagues, including Ingo Jordan and Holger Bernhardt. Their combined efforts in research and development have furthered advancements in the field of vaccine technology.
Conclusion
Stefan Hartmann's contributions to vaccine development through his innovative patent and collaboration with industry professionals highlight his commitment to improving public health. His work continues to influence the future of vaccine production and safety.